IP Library Granted Patent US 11,261,401
Granted Patent B2
US 11,261,401 · App. 16/637,401 · Granted Mar 1, 2022

Synthesis of 1,3-olein-2-palmitin (OPO)

Inventors: Frederic Destaillats (Servion, CH); Francesca Giuffrida (Mezieres, CH); Amaury Patin (Lausanne, CH)
Assignee: Societe des Produits Nestle S.A.
C11C3/003A23D9/02C07C29/132C07C29/136
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,261,401
App. No.
16/637,401
Granted
Mar 1, 2022
Kind
B2
Abstract

The present invention concerns a highly selective process for the preparation of an ingredient comprising 1,3-Olein-2-palmitin (OPO), a triglyceride present in human breast milk. The present invention also relates to 1,3-Olein-2-palmitin (OPO) ingredient obtainable by the process.

Claims (20)

1. A process for preparation of a 1,3-Olein-2-palmitin ingredient, the process comprising:

subjecting 2-oxopropane-1,3-diyl dioleate to a reduction reaction under an anhydrous condition in a solvent system comprising tetrahydrofurane and in the presence of sodium borohydride to yield 2-hydroxypropane-1,3-diyl dioleate;

partially removing and replacing the tetrahydrofurane with a solvent which is not miscible with water;

adding acidulated water to inactivate the sodium borohydrate to form an inactivated mixture;

separating an organic phase of the inactivated mixture;

evaporating the solvent to recover the 2-hydroxypropane-1,3-diyl dioleate; and

reacting the 2-hydroxypropane-1,3-diyl dioleate with palmitoyl chloride to yield the 1,3-Olein-2-palmitin.

2. The process according to claim 1 comprising:

reacting 1,3-dihydroxyacetone with oleic acid or oleoyl chloride to yield the 2-oxopropane-1,3-diyl dioleate.

3. The process according to claim 1 comprising reacting 1,3-dihydroxyacetone in chloroform with oleoyl chloride in the presence of 2,6-lutidine at a temperature ranging from 0° C. to 25° C. to yield the 2-oxopropane-1,3-diyl dioleate.

4. The process according to claim 1 , wherein the solvent system consists of the tetrahydrofurane.

5. The process according to claim 1 , wherein the solvent system is selected from the group consisting of the tetrahydrofurane, the tetrahydrofurane/MeOH, the tetrahydrofurane/EtOH, and the tetrahydrofurane/MeOH/EtOH.

6. The process according to claim 1 , wherein the reduction reaction is performed at a temperature lower than 25° C.

7. The process according to claim 1 comprising reacting 1,3-dihydroxyacetone in chloroform with oleoyl chloride in the presence of pyridine or a pyridine derivative at a temperature ranging from 0° C. to 25° C. to yield the 2-oxopropane-1,3-diyl dioleate.

8. A 1,3-Olein-2-palmitin ingredient comprising a palmitic acid content at sn-2 position greater than 70% of a total palmitic content and by having a weight ratio of 1,3-Olein-2-palmitin to 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) equal or higher than 90:10.

9. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the palmitic acid content at sn-2 position is equal or greater than 75% of the total palmitic content.

10. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 92:8.

11. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate), or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 95:5.

12. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the weight ratio of the 1,3-Olein-2-palmitin to the 3-(Palmitoyloxy)-1,2-propanediyl (9Z,9′Z)bis(-9-octadecenoate) or to the 1-(Palmitoyloxy)-2,3-propanediyl (9Z,9′Z)bis(-9-octadecenoate) is equal or greater than 98:2.

13. The 1,3-Olein-2-palmitin ingredient according to claim 8 , wherein the palmitic acid content at sn-2 position is equal or greater than 80% of the total palmitic content.

Assignments (2)
MERGER Recorded Dec 7, 2021
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 058317/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2021
From: DESTAILLATS, FREDERIC; GIUFFRIDA, FRANCESCA; PATIN, AMAURY
To: NESTEC S.A.
Reel/Frame 058345/0632 →
Priority Claims (1)
EP 17185991 · Aug 11, 2017 · regional
Continuity (1)
Related Publication 20200190430A1 · Jun 18, 2020